Skip to main content
. 2022 Sep 20;2022:6407344. doi: 10.1155/2022/6407344

Figure 5.

Figure 5

Integrative analyses of tumor mutation burden (TMB) and stromal/immune scores. (a) TMB levels in patients with high and low stromal/immune scores; P ≤ 0.05. (b) The survival difference between patients with high and low levels of TMB. (c) The survival difference among four groups of patients classified according to the level of TMB and stromal score. (d) The survival difference among four groups of patients stratified according to the levels of TMB and immune score.